Related Experiment Video
Updated: Aug 10, 2026
12:04
Assessment of the Cytotoxic and Immunomodulatory Effects of Substances in Human Precision-cut Lung Slices
Published on: May 9, 2018
Pleural plaques and lung function in construction workers exposed to asbestos
European Journal of Respiratory Diseases
|January 1, 1981
Summary
Asbestos exposure in construction workers with pleural plaques can lead to small airway disease. This asbestos-related pulmonary dysfunction showed reduced expiratory flow rates and increased closing volume.
Area of Science:
- Occupational Medicine
- Pulmonary Medicine
- Environmental Health
Background:
- Asbestos exposure is a known risk factor for respiratory diseases.
- Construction workers are a population at risk for asbestos exposure.
- The impact of asbestos exposure on small airways requires further investigation.
Purpose of the Study:
- To evaluate respiratory symptoms and pulmonary function in asbestos-exposed construction workers.
- To identify specific pulmonary function changes associated with asbestos exposure, particularly in relation to pleural plaques.
- To differentiate the effects of asbestos exposure from smoking on lung function.
Main Methods:
- Study included three groups: asbestos-exposed with pleural plaques (Group I), asbestos-exposed without pleural plaques (Group II), and non-exposed controls (Group III).
- Respiratory symptoms were assessed through questionnaires.
- Pulmonary function was evaluated using spirometry, including measurements of maximal expiratory flow rates (MEF50, MEF25), closing volume (CV), and transfer factor for carbon monoxide (CO).
Main Results:
- Group I (asbestos-exposed with pleural plaques) showed a 4-5 times higher frequency of chronic bronchitis and productive cough compared to controls (Group III).
- Significant reductions in expiratory flow rates (MEF50, MEF25) and a marked increase in closing volume (CV) were observed in Group I.
- The differences in CV, MEF50, and MEF25 were more pronounced between exposed and non-exposed non-smokers than between exposed and non-exposed smokers. Group II showed no significant differences compared to controls.
Conclusions:
- Asbestos exposure, even when primarily manifesting as pleural plaques, can cause pulmonary dysfunction.
- The observed changes in MEF50, MEF25, and CV suggest that asbestos exposure leads to small airway disease.
- Pulmonary function impairment in asbestos-exposed individuals may be independent of smoking status, highlighting the direct impact of asbestos.
Related Concept Videos
01:13Pleura of the Lungs
The lungs are nestled in a cavity, shielded by the pleura. The pleura, a form of serous membrane, wraps around each lung. This membrane arrangement consists of two layers: the visceral and parietal pleurae. The visceral pleura lines the surface of the lungIn contrast, the parietal pleura is the outer layer and contacts to the thoracic wall, the mediastinum, and the diaphragm. The hilum is the point of connection between the visceral and parietal layers. The space between the parietal and...
01:30Pleural Disorders: Types and Brief Description
The pleura is a vital part of the respiratory system. It's a double-layered membrane surrounding the lungs and lining the chest cavity. The two layers of the pleura are:
01:25Pleural Effusion I: Introduction
Pleural effusion is an abnormal fluid accumulation in the pleural cavity, a narrow space between the lungs and the chest wall. It is not a disease per se but rather a symptom or indication of an underlying disease. In normal circumstances, this space contains a small amount of fluid (5 to 15 mL), a lubricant facilitating the non-frictional movement of the pleural surfaces.
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's criteria,...
01:27Pneumothorax-II
Pneumothorax is a medical condition defined by the buildup of air in the pleural space between the lungs and the chest wall. This accumulation of air can lead to partial or complete lung collapse, resulting in a range of clinical manifestations. Understanding the clinical presentation and effective management strategies is crucial for healthcare professionals in providing timely and appropriate care to individuals with pneumothorax.
Clinical Manifestations:
Clinical Manifestations:
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...